Position in NVS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,011,814
+$50,963 QoQ
Shares Held
12,837
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#428
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $421,884,223 across 14 Drug Manufacturers - General names. NVS ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
596,837 | $150,188,062 | |
| 2 | JNJ |
Johnson & Johnson
|
391,709 | $99,482,334 | |
| 3 | LLY |
ELI LILLY & Co
|
53,616 | $64,308,643 | |
| 4 | AMGN |
Amgen Inc
|
167,825 | $60,772,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
172,406 | $22,154,171 | |
| 6 | PFE |
Pfizer Inc
|
453,303 | $10,915,536 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
113,175 | $6,521,142 | |
| 8 | AZN |
Astrazeneca PLC
|
20,928 | $3,968,367 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,011,814 | 12,837 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,960,851 | 12,837 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,800,581 | 13,060 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,700,718 | 13,262 | Shares | Other | 2025-10-17 | |
| 2025-06-30 | $394,734 | 3,262 | Shares | Sole | 2025-10-17 | |
| 2025-03-31 | $458,405 | 4,112 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $395,272 | 4,062 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $363,807 | 3,163 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $298,620 | 2,805 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $271,327 | 2,805 | Shares | Sole | 2024-06-20 | |
| 2023-12-31 | $283,220 | 2,805 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $300,996 | 2,955 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $245,211 | 2,430 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $221,260 | 2,405 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $284,497 | 3,136 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $356,410 | 4,689 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $286,894 | 3,394 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $319,322 | 3,639 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $299,934 | 3,429 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $247,548 | 3,027 | Shares | Sole | 2021-11-30 | |
| 2021-06-30 | $273,628 | 2,999 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $272,339 | 3,186 | Shares | Sole | 2021-06-15 | |
| 2020-12-31 | $246,745 | 2,613 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $275,924 | 3,173 | Shares | Sole | 2020-12-21 | |
| 2020-06-30 | $251,189 | 2,876 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $237,126 | 2,876 | Shares | Sole | 2020-07-01 | |
| No filing history on record for this holder in this stock. | ||||||